4//SEC Filing
Bellerophon Therapeutics, Inc. 4
Accession 0001600132-16-000104
CIK 0001600132operating
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 8:11 PM ET
Size
4.6 KB
Accession
0001600132-16-000104
Insider Transaction Report
Form 4
Fernandes Peter
Chief Regulatory Officer
Transactions
- Tax Payment
Common Stock
2016-09-12$1.38/sh−19,785$27,303→ 35,722 total
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001600132
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 8:11 PM ET
- Size
- 4.6 KB